Share-based Payment Arrangement, Expense of Phreesia, Inc. from 31 Jan 2020 to 31 Jul 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Phreesia, Inc. quarterly and annual Share-based Payment Arrangement, Expense in USD history and change rate from 31 Jan 2020 to 31 Jul 2025.
  • Phreesia, Inc. Share-based Payment Arrangement, Expense for the quarter ending 31 Jul 2025 was $16,230,000, a 1.3% decline year-over-year.
  • Phreesia, Inc. Share-based Payment Arrangement, Expense for the twelve months ending 31 Jul 2025 was $67,142,000, a 2.9% decline year-over-year.
  • Phreesia, Inc. annual Share-based Payment Arrangement, Expense for 2024 was $66,975,000, a 6.5% decline from 2023.
  • Phreesia, Inc. annual Share-based Payment Arrangement, Expense for 2023 was $71,613,000, a 22% increase from 2022.
  • Phreesia, Inc. annual Share-based Payment Arrangement, Expense for 2022 was $58,775,000, a 62% increase from 2021.
Source SEC data
View on sec.gov
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Change (%)
Share-based Payment Arrangement, Expense, Annual (USD)
Share-based Payment Arrangement, Expense, YoY Annual Change (%)

Phreesia, Inc. Quarterly Share-based Payment Arrangement, Expense (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q2 2025 $67,142,000 $16,230,000 -$218,000 -1.3% 01 May 2025 31 Jul 2025 10-Q 05 Sep 2025 2026 Q2
Q1 2025 $67,360,000 $17,225,000 +$385,000 +2.3% 01 Feb 2025 30 Apr 2025 10-Q 28 May 2025 2026 Q1
Q4 2024 $66,975,000 $17,162,000 -$702,000 -3.9% 01 Nov 2024 31 Jan 2025 10-K 13 Mar 2025 2025 FY
Q3 2024 $67,677,000 $16,525,000 -$1,438,000 -8% 01 Aug 2024 31 Oct 2024 10-Q 09 Dec 2024 2025 Q3
Q2 2024 $69,115,000 $16,448,000 -$2,200,000 -12% 01 May 2024 31 Jul 2024 10-Q 05 Sep 2025 2026 Q2
Q1 2024 $71,315,000 $16,840,000 -$298,000 -1.7% 01 Feb 2024 30 Apr 2024 10-Q 28 May 2025 2026 Q1
Q4 2023 $71,613,000 $17,864,000 +$2,580,000 +17% 01 Nov 2023 31 Jan 2024 10-K 13 Mar 2025 2025 FY
Q3 2023 $69,033,000 $17,963,000 +$3,181,000 +22% 01 Aug 2023 31 Oct 2023 10-Q 09 Dec 2024 2025 Q3
Q2 2023 $65,852,000 $18,648,000 +$4,090,000 +28% 01 May 2023 31 Jul 2023 10-Q 05 Sep 2024 2025 Q2
Q1 2023 $61,762,000 $17,138,000 +$2,987,000 +21% 01 Feb 2023 30 Apr 2023 10-Q 31 May 2024 2025 Q1
Q4 2022 $58,775,000 $15,284,000 +$5,026,000 +49% 01 Nov 2022 31 Jan 2023 10-K 13 Mar 2025 2025 FY
Q3 2022 $53,749,000 $14,782,000 +$1,853,000 +14% 01 Aug 2022 31 Oct 2022 10-Q 06 Dec 2023 2024 Q3
Q2 2022 $51,896,000 $14,558,000 +$7,285,000 +100% 01 May 2022 31 Jul 2022 10-Q 07 Sep 2023 2024 Q2
Q1 2022 $44,611,000 $14,151,000 +$8,377,000 +145% 01 Feb 2022 30 Apr 2022 10-Q 01 Jun 2023 2024 Q1
Q4 2021 $36,234,000 $10,258,000 01 Nov 2021 31 Jan 2022 10-K 15 Mar 2024 2024 FY
Q3 2021 $12,929,000 +$9,613,000 +290% 01 Aug 2021 31 Oct 2021 10-Q 09 Dec 2022 2023 Q3
Q2 2021 $7,273,000 +$3,845,000 +112% 01 May 2021 31 Jul 2021 10-Q 08 Sep 2022 2023 Q2
Q1 2021 $5,774,000 01 Feb 2021 30 Apr 2021 10-Q 03 Jun 2022 2023 Q1
Q3 2020 $3,316,000 01 Aug 2020 31 Oct 2020 10-Q 09 Dec 2021 2022 Q3
Q2 2020 $3,428,000 01 May 2020 31 Jul 2020 10-Q 02 Sep 2021 2022 Q2

Phreesia, Inc. Annual Share-based Payment Arrangement, Expense (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2024 $66,975,000 -$4,638,000 -6.5% 01 Feb 2024 31 Jan 2025 10-K 13 Mar 2025 2025 FY
2023 $71,613,000 +$12,838,000 +22% 01 Feb 2023 31 Jan 2024 10-K 13 Mar 2025 2025 FY
2022 $58,775,000 +$22,541,000 +62% 01 Feb 2022 31 Jan 2023 10-K 13 Mar 2025 2025 FY
2021 $36,234,000 +$22,745,000 +169% 01 Feb 2021 31 Jan 2022 10-K 15 Mar 2024 2024 FY
2020 $13,489,000 +$7,312,000 +118% 01 Feb 2020 31 Jan 2021 10-K 23 Mar 2023 2023 FY
2019 $6,177,000 01 Feb 2019 31 Jan 2020 10-K 31 Mar 2022 2022 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.